Search results
AHN Honors Neurosciences
Erie News Now Plus· 6 hours agoThe event featured music, dinner and charity auctions, with the money raised benefiting neurosciences at the hospital.
Challenging Old Theories: Innovative Microscopy Exposes New Alzheimer’s Treatment Pathways
SciTechDaily· 5 hours agoResearchers at UC San Diego have utilized advanced imaging techniques to explore the metabolic...
Neuroscientists warn of "cascading" Alzheimer's risk from these two habits
Newsweek· 23 hours agoTwo common habits could be putting you at an increased risk of Alzheimer's and related dementias,...
Alto Neuroscience schizophrenia treatment shows good phase 1 results
Seeking Alpha· 4 days agoALTO-101, a PDE4 inhibitor by Alto Neuroscience, shows promising results in phase 1 trial for...
Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves
Motley Fool via Yahoo Finance· 3 hours agoThat can provide up-front capital to expand its operations. The company already has partnerships in...
New Haven and neuroscience: Match made in heaven?
Hartford Business Journal· 2 days agoThe announcement last spring by Yale New Haven Health of plans to develop an $838 million neurosciences facility on its St. Raphael campus marked New...
Naps Crucial For Brain Development and Memory in Kids - Neuroscience News
Neuroscience News· 2 days agoSummary: A new study aims to examine the role of napping in brain development among infants and...
▶️ Listen Now: The benefits of teaching kids about neuroscience
WBEZ 91.5 Chicago· 4 days agoWhen people are science literate, they could be more health literate too.
Treatment Patch For Schizophrenia: Newly Listed Alto Neuroscience Is Uniquely Positioned In...
Benzinga via Yahoo Finance· 4 days agoRecently listed Alto Neuroscience Inc (NYSE:ANRO) released results from its healthy volunteer Phase...
Alto Neuroscience reports positive Phase 1 results for ALTO-101 By Investing.com
Investing.com· 4 days agoAlto Neuroscience, Inc. (NYSE: ANRO) announced today that its Phase 1 study of ALTO-101, a novel...